Speaker
Ms
Marie-Charlotte RICOL
(Institut de physique nucléaire de Lyon (IPNL) - Université Claude Bernard Lyon 1 (UCBL))
Description
Heavy charged particles like protons or light atom nuclei like carbon ions have
interesting ballistic properties in cancer therapy. When used as projectiles,
their electromagnetic interaction with matter is characterized with an energy loss
spectrum peaking at a localized penetration depth: the so called Bragg peak. This
feature, combined with a raster scanned beam modulated in energy and intensity, is
used in hadrontherapy to deliver volumetric dose distributions that conform to the
physician prescriptions. Thus, it optimizes the energy deposition in the target
volume (tumor) and spears the surrounding media. However, projectile particles used
in hadrontherapy have sufficient kinetic energies to undergo nuclear reactions with
target nuclei. As a consequence, depending on the nuclear process involved,
multiple nuclear fragments can be produced. Even though the cross section of these
processes would hardly exceed 40% of the total interaction cross section, they
would contribute to a significant spread of the deposited dose over the target
volume of interest. Despite this unwanted effect in hadrontherapy, among the
produced radioactive isotopes, a small fraction of those is β+ emitter and offers
the only way for an online dose deposition control and even more the only way for
the exploitation of inline and in-situ PET (Positron Emission Tomography)
techniques for real time imaging.
Here, we present our preliminary results concerning simulation studies of an inline
PET prototype using the dose dependent predicted β+ emitters distributions for a
real time control of a treatment plan in hadrontherapy.
Author
Ms
Marie-Charlotte RICOL
(Institut de physique nucléaire de Lyon (IPNL) - Université Claude Bernard Lyon 1 (UCBL))